"Executive Summary Viral Vector and Vaccine Market Size and Share Across Top Segments Data Bridge Market Research analyses that the viral vector and vaccine market which is USD 513.43 million in 2022, is expected to reach USD 2016.62 million by 2030, at a CAGR of 18.65% during the forecast period 2023 to 2030.To better structure this Viral Vector and Vaccine report, a nice blend of...

According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...